IV Infusion News
Featured & Company News
We invite you to learn more about how Infusion Ventures can assist with your infusion therapy needs, whether home infusions or other specialty therapy needs. Visit infusionventures.com today.
Our expertise is management of chronic care diagnoses, our experience is broad and includes hemophilia and Von Willebrands, IVIG, immune deficiencies, Gauchers, HAE , neurological disorders, MPS, and catheter care. Infusion nursing services support both on demand...
Infusion Ventures wishes our clients and colleagues a wonderful start to 2025 – and we look forward to working together in the year ahead!
As we welcome the coming New Year ahead, Infusion Ventures would like to say thank you to our clients and colleagues who trust our dedicated team of nursing and administrative professionals for their infusion nursing needs. We look forward to working together with you...
We wish all of our patients, colleagues and friends a healthy and happy holiday season and best wishes for a wonderful New Year!
We wish all of our patients, colleagues and friends a healthy and happy holiday season and best wishes for a wonderful New Year! We would like to take this time to also thank our dedicated nurses for their dedication and professionalism throughout the year. Warmest...
Infusion Ventures has specialized in pediatric infusion nursing care since 1993 and we continue to carry a large caseload of pediatric patients throughout New England. To learn more about our pediatric nursing services, contact us today at (781) 938-7070 or learn more at infusionventures.com.
We are steadfast in being your child's advocate for better health. Infusion Ventures administers infused medications to children including Hemophilia treatments, Enzyme Replacement Therapy and Immune Deficiency Treatments. Our nurses are trained and experienced in...
Industry News
‘Reverse Vaccination’ May Help Prevent Immune Response | Hemophilia News Today
From Hemophilia News Today: A newly designed platform based on the principle of “reverse vaccination” could be used to prevent the development of an immune response that blocks the effectiveness of treatments for hemophilia and other disorders. Continue reading:...
Advocates Lobby US Congress During Virtual Rare Disease Week
This year’s event featured 250 patient organizations and 367 meetings with Congress. Original Source: Advocates Lobby US Congress During Virtual Rare Disease Week
Statement from NHIA on CMS’ Medicare Payment Rate Increase for Monoclonal Antibody Treatments
Earlier this year, The NHIA (The National Home Infusion Association) issued a statement regarding the decision to increase Medicare payment rates for monoclonal antibody administration. See the original press release below for more details. Alexandria, Va. (May 6,...
COVID-19 Vaccines and Primary Immunodeficiency | CSL Behring
Can PI patients get the vaccine and will it work for them? A doctor who advises the Immune Deficiency Foundation offers her perspective. Source article: COVID-19 Vaccines and Primary Immunodeficiency
Should Parents Be Freaking Out About a New COVID Syndrome Found in Kids?
Doctors have had success using treatment methods that are already widely known to be effective for inflammatory symptoms in children, including intravenous immunoglobulin, or IVIG. Source: Should Parents Be Freaking Out About a New COVID Syndrome Found in Kids?
Examining the Application of Ig in Multiple Disease States | IgNS – Advancing Ig Therapy Practice
Examining the Application of Immunoglobulin in Multiple Disease States: A Review of Evidence Source: Examining the Application of Ig in Multiple Disease States | IgNS - Advancing Ig Therapy Practice
Update on Crohn’s Disease from IG Living
Update on Crohn's Disease from IG Living or [button...
Hemophilia A Patients Using Hemlibra Show Gains in Joint Health, Trial Data Show | Hemophilia News Today
Source: Hemophilia A Patients Using Hemlibra Show Gains in Joint Health, Trial Data Show
Breaking into the Boys Club: Women with Hemophilia
Since hemophilia was discovered, it has been accepted as a male disease. No one questions that a man is struggling with hemophilia. A man with a bleeding disorder living in a developed country is rarely denied access to healthcare. When he receives a diagnosis, he is...
Data: Hemlibra OK in Kids with Hemophilia A Regardless of Inhibitor Status
Preventive treatment with Hemlibra reduces bleeding rates in children younger than 12 with hemophilia type A regardless of inhibitor status, data show. Source: Data: Hemlibra OK in Kids with Hemophilia A Regardless of Inhibitor Status